Concepedia

Hylke Waalewijn

HW

Statistics

Publications

8

Citations

399

H-Index

8

Active since

2022

Affiliations

University College London(Current)

Medical Research Council

University of Zimbabwe

Radboud University Medical Center

Radboud University Nijmegen

Hylke Waalewijn is an author at University College London specializing in pharmacy, antiretroviral therapy, and pediatric antiretroviral therapy.

ORCID

Publications per year

2022–2023

8

Publications

8

Major revision version 12.0 of the European <scp>AIDS</scp> Clinical Society guidelines 2023

Juan Ambrosioni, Laura Levi, Jasmini Alagaratnam et al. · HIV Medicine · 2023 · 167 citations · Full text

, , +17

Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021

Lene Ryom, Rosa de Miguel Buckley, Aoife G. Cotter et al. · HIV Medicine · 2022 · 106 citations · Full text

, , +17

Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Hylke Waalewijn, Man K. Chan, Pauline Bollen et al. · The Lancet HIV · 2022 · 38 citations · Full text

, , +14

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Pauline Amuge, Abbas Lugemwa, Ben Wynne et al. · The Lancet HIV · 2022 · 31 citations · Full text

, , +15

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Anna Turkova, Hylke Waalewijn, Man K. Chan et al. · The Lancet HIV · 2022 · 24 citations · Full text

, , +17

1–5 of 8